QY Research has Published Latest Trending Report on Global Gene Therapy Market
Los Angeles, United State, The report titledGlobal Gene Therapy Marketis one of the most comprehensive and important additions to QY Researchs archive of market research studies. It offers detailed research and analysis of key aspects of the global Gene Therapy market. The market analysts authoring this report have provided in-depth information on leading growth drivers, restraints, challenges, trends, and opportunities to offer a complete analysis of the global Gene Therapy market. Market participants can use the analysis on market dynamics to plan effective growth strategies and prepare for future challenges beforehand. Each trend of the global Gene Therapy market is carefully analyzed and researched about by the market analysts.
Request Sample Report and Full Report TOC:https://www.qyresearch.com/sample-form/form/1436547/global-gene-therapy-market
The Essential Content Covered in the GlobalGene Therapy Market Report:
* Top Key Company Profiles.* Main Business and Rival Information* SWOT Analysis and PESTEL Analysis* Production, Sales, Revenue, Price and Gross Margin* Market Share and Size
Global Gene Therapy Market is estimated to reach xxx million USD in 2020 and projected to grow at the CAGR of xx% during 2020-2026. According to the latest report added to the online repository of QY Research the Gene Therapy market has witnessed an unprecedented growth till 2020. The extrapolated future growth is expected to continue at higher rates by 2025.
Top Players of Gene Therapy Market are Studied: Bluebird Bio, Sangamo, Spark Therapeutics, Dimension Therapeutics, Avalanche Bio, Celladon, Vical Inc., Advantagene
The report provides a 6-year forecast (2020-2026) assessed based on how the Gene Therapy market is predicted to grow in major regions likeUSA, Europe, Japan, China, India, Southeast Asia, South America, South Africa, Others.
Segmentation by Type:Ex vivoIn Vivo
Segmentation by Application:CancerMonogenicInfectious diseaseCardiovascular diseaseOther
Reasons to Buy this Report:
Table of Contents
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Gene Therapy Revenue
1.4 Market Analysis by Type
1.4.1 Global Gene Therapy Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Ex vivo
1.4.3 In Vivo
1.5 Market by Application
1.5.1 Global Gene Therapy Market Share by Application: 2020 VS 2026
1.5.2 Cancer
1.5.3 Monogenic
1.5.4 Infectious disease
1.5.5 Cardiovascular disease
1.5.6 Other 1.6 Study Objectives 1.7 Years Considered2 Global Growth Trends by Regions
2.1 Gene Therapy Market Perspective (2015-2026)
2.2 Gene Therapy Growth Trends by Regions
2.2.1 Gene Therapy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Gene Therapy Historic Market Share by Regions (2015-2020)
2.2.3 Gene Therapy Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porters Five Forces Analysis
2.3.5 Gene Therapy Market Growth Strategy
2.3.6 Primary Interviews with Key Gene Therapy Players (Opinion Leaders)3 Competition Landscape by Key Players
3.1 Global Top Gene Therapy Players by Market Size
3.1.1 Global Top Gene Therapy Players by Revenue (2015-2020)
3.1.2 Global Gene Therapy Revenue Market Share by Players (2015-2020)
3.1.3 Global Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Gene Therapy Market Concentration Ratio
3.2.1 Global Gene Therapy Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Gene Therapy Revenue in 2019
3.3 Gene Therapy Key Players Head office and Area Served
3.4 Key Players Gene Therapy Product Solution and Service
3.5 Date of Enter into Gene Therapy Market
3.6 Mergers & Acquisitions, Expansion Plans4 Breakdown Data by Type (2015-2026)
4.1 Global Gene Therapy Historic Market Size by Type (2015-2020)
4.2 Global Gene Therapy Forecasted Market Size by Type (2021-2026)5 Gene Therapy Breakdown Data by Application (2015-2026)
5.1 Global Gene Therapy Market Size by Application (2015-2020)
5.2 Global Gene Therapy Forecasted Market Size by Application (2021-2026)6 North America
6.1 North America Gene Therapy Market Size (2015-2020)
6.2 Gene Therapy Key Players in North America (2019-2020)
6.3 North America Gene Therapy Market Size by Type (2015-2020)
6.4 North America Gene Therapy Market Size by Application (2015-2020)7 Europe
7.1 Europe Gene Therapy Market Size (2015-2020)
7.2 Gene Therapy Key Players in Europe (2019-2020)
7.3 Europe Gene Therapy Market Size by Type (2015-2020)
7.4 Europe Gene Therapy Market Size by Application (2015-2020)8 China
8.1 China Gene Therapy Market Size (2015-2020)
8.2 Gene Therapy Key Players in China (2019-2020)
8.3 China Gene Therapy Market Size by Type (2015-2020)
8.4 China Gene Therapy Market Size by Application (2015-2020)9 Japan
9.1 Japan Gene Therapy Market Size (2015-2020)
9.2 Gene Therapy Key Players in Japan (2019-2020)
9.3 Japan Gene Therapy Market Size by Type (2015-2020)
9.4 Japan Gene Therapy Market Size by Application (2015-2020)10 Southeast Asia
10.1 Southeast Asia Gene Therapy Market Size (2015-2020)
10.2 Gene Therapy Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Gene Therapy Market Size by Type (2015-2020)
10.4 Southeast Asia Gene Therapy Market Size by Application (2015-2020)11 India
11.1 India Gene Therapy Market Size (2015-2020)
11.2 Gene Therapy Key Players in India (2019-2020)
11.3 India Gene Therapy Market Size by Type (2015-2020)
11.4 India Gene Therapy Market Size by Application (2015-2020)12 Central & South America
12.1 Central & South America Gene Therapy Market Size (2015-2020)
12.2 Gene Therapy Key Players in Central & South America (2019-2020)
12.3 Central & South America Gene Therapy Market Size by Type (2015-2020)
12.4 Central & South America Gene Therapy Market Size by Application (2015-2020)13Key Players Profiles
13.1 Bluebird Bio
13.1.1 Bluebird Bio Company Details
13.1.2 Bluebird Bio Business Overview and Its Total Revenue
13.1.3 Bluebird Bio Gene Therapy Introduction
13.1.4 Bluebird Bio Revenue in Gene Therapy Business (2015-2020))
13.1.5 Bluebird Bio Recent Development
13.2 Sangamo
13.2.1 Sangamo Company Details
13.2.2 Sangamo Business Overview and Its Total Revenue
13.2.3 Sangamo Gene Therapy Introduction
13.2.4 Sangamo Revenue in Gene Therapy Business (2015-2020)
13.2.5 Sangamo Recent Development
13.3 Spark Therapeutics
13.3.1 Spark Therapeutics Company Details
13.3.2 Spark Therapeutics Business Overview and Its Total Revenue
13.3.3 Spark Therapeutics Gene Therapy Introduction
13.3.4 Spark Therapeutics Revenue in Gene Therapy Business (2015-2020)
13.3.5 Spark Therapeutics Recent Development
13.4 Dimension Therapeutics
13.4.1 Dimension Therapeutics Company Details
Original post:
- About the Gene Therapy Review - November 8th, 2009 [November 8th, 2009]
- Contribute an Article - November 8th, 2009 [November 8th, 2009]
- EBSCO Publishing Deal - November 8th, 2009 [November 8th, 2009]
- Advertising Opportunities - November 8th, 2009 [November 8th, 2009]
- Instructions for Authors - November 8th, 2009 [November 8th, 2009]
- Isis Collaboration With Ortho-McNeil Inc for Metabolic Diseases - November 8th, 2009 [November 8th, 2009]
- Dystrophin Gene Transfer safe in Duchenne muscular dystrophy - November 8th, 2009 [November 8th, 2009]
- Researchers Identify Gene for Rare Form of Spinal Muscular Atrophy - November 8th, 2009 [November 8th, 2009]
- Fatal brain cancer tamed by New gene therapy - November 8th, 2009 [November 8th, 2009]
- Gene therapy effective in fighting obesity in mice - November 8th, 2009 [November 8th, 2009]
- Genzyme gene therapy for people with peripheral artery disease failed in a clinical trial to help them regain some mobility - November 8th, 2009 [November 8th, 2009]
- Gene Therapy May Stall Inherited Emphysema - December 31st, 2009 [December 31st, 2009]
- Gene Therapy and Stem Cells Save Limb - December 31st, 2009 [December 31st, 2009]
- TNVitamins.com – $10 Off Of $50 order - May 7th, 2011 [May 7th, 2011]
- 15% Off Any PetAlive Order - May 7th, 2011 [May 7th, 2011]
- At PetAlive – $10 off order of $50 or more - May 7th, 2011 [May 7th, 2011]
- Native Remedies coupon – 5% Off Any Order - May 7th, 2011 [May 7th, 2011]
- Native Remedies – Save $5 coupon - May 7th, 2011 [May 7th, 2011]
- Welcome to the Gene Therapy Review - May 15th, 2011 [May 15th, 2011]
- Editorial Board - May 15th, 2011 [May 15th, 2011]
- Gene Therapy Job Board - May 15th, 2011 [May 15th, 2011]
- Corporate Membership - May 22nd, 2011 [May 22nd, 2011]
- Native Remedies coupon – 25% Off Any Order - May 29th, 2011 [May 29th, 2011]
- What is Gene Therapy? - June 19th, 2011 [June 19th, 2011]
- Research and Markets: Recent Advances in Cancer Research and Therapy - Increased Research on one of the Major Causes ... - April 25th, 2012 [April 25th, 2012]
- Gene Therapy part 2 - Video - April 30th, 2012 [April 30th, 2012]
- Gene therapy reverses Parkinson's symptoms: study - Video - April 30th, 2012 [April 30th, 2012]
- CBS This Morning - Gene therapy reverses Parkinson's symptoms: study - Video - April 30th, 2012 [April 30th, 2012]
- Engineering adenoviruses for gene therapy - Video - April 30th, 2012 [April 30th, 2012]
- What is Gene Therapy (The General Explains) - Video - April 30th, 2012 [April 30th, 2012]
- What is Gene Therapy - Animation - Video - April 30th, 2012 [April 30th, 2012]
- Microbiology Gene Therapy - Video - April 30th, 2012 [April 30th, 2012]
- Gene Therapy in Detail - Video - April 30th, 2012 [April 30th, 2012]
- Breakthrough in Haemophilia treatment - Video - April 30th, 2012 [April 30th, 2012]
- Virology Seminar - Gene Therapy - April 30th, 2012 [April 30th, 2012]
- Gene Therapy Video - Video - April 30th, 2012 [April 30th, 2012]
- Study: Gene Therapy for HIV Safe, But Effectiveness Still Unclear - May 4th, 2012 [May 4th, 2012]
- Gene Therapy Safe in Decade-Long HIV Study That May Widen Use - May 4th, 2012 [May 4th, 2012]
- Gene therapy for HIV safe, but effectiveness still unclear - May 4th, 2012 [May 4th, 2012]
- A Step Forward For Gene Therapy To Treat HIV - May 4th, 2012 [May 4th, 2012]
- A Media Event on Clinical Developments in Gene and Cell Therapy - May 4th, 2012 [May 4th, 2012]
- Families of SMA Awards New Funding to Advance a CNS Delivered Gene Therapy for Spinal Muscular Atrophy - May 4th, 2012 [May 4th, 2012]
- AIDS gene therapy safe -- is it a "cure"? - May 4th, 2012 [May 4th, 2012]
- Generational Achievements in Gene and Cell Therapy Honored at ASGCT 15th Annual Meeting - May 5th, 2012 [May 5th, 2012]
- Lewis speaks on gene therapy at Lexington Community Education event - May 7th, 2012 [May 7th, 2012]
- Penn researchers report a gene-therapy success - May 10th, 2012 [May 10th, 2012]
- Gene therapy for hearing loss: Potential and limitations - May 13th, 2012 [May 13th, 2012]
- Gene therapy extends mouse lifespan by 24 pc - May 16th, 2012 [May 16th, 2012]
- Gene therapy dramatically extends mouse lifespan - May 16th, 2012 [May 16th, 2012]
- Gene therapy may extend life: Study - May 16th, 2012 [May 16th, 2012]
- First gene therapy successful against aging-associated decline: Mouse lifespan extended up to 24% with a single ... - May 16th, 2012 [May 16th, 2012]
- Gene Therapy Extends Mouse Lifespan - May 16th, 2012 [May 16th, 2012]
- Gene Therapy for Brain Disease - May 17th, 2012 [May 17th, 2012]
- Children with rare, incurable brain disease improve after gene therapy - May 17th, 2012 [May 17th, 2012]
- FIRST Anti-Aging Gene Therapy (Brainstorm Ep72) - Video - May 23rd, 2012 [May 23rd, 2012]
- Gene therapy can correct forms of severe combined immunodeficiency - May 25th, 2012 [May 25th, 2012]
- RetroSense Therapeutics Completes pre-IND Meeting for RST-001 - May 25th, 2012 [May 25th, 2012]
- Gene therapy can correct forms of severe combined immunodeficiency, study suggests - May 26th, 2012 [May 26th, 2012]
- Alliance for Cancer Gene Therapy celebrates 10 years - May 29th, 2012 [May 29th, 2012]
- Research on gene therapy by Prasad Eye - June 1st, 2012 [June 1st, 2012]
- Baxter Announces Collaboration with Chatham Therapeutics for Factor IX Hemophilia B Gene Therapy Treatment - June 5th, 2012 [June 5th, 2012]
- Transgenomic Launches Breakthrough Blood-Based Cancer Gene Testing Technology at 2012 ASCO Annual Meeting - June 5th, 2012 [June 5th, 2012]
- Baxter Inks Deal with Chatham - June 6th, 2012 [June 6th, 2012]
- PIK3CA Gene Patent for Predicting Response to Targeted Therapy Issued – Exclusively Licensed to Transgenomic - June 11th, 2012 [June 11th, 2012]
- SalutarisMD Announces Positive Case Report of a New Investigational Wet AMD Therapy at ARVO - June 15th, 2012 [June 15th, 2012]
- Research and Markets: Gene Therapy - Global Strategic Business Report - 2012 - June 15th, 2012 [June 15th, 2012]
- New York Law Firm’s MesotheliomaHelp.net Site Publishes Interview with Gene Therapy Author - June 17th, 2012 [June 17th, 2012]
- uniQure Extends Collaboration with Protein Sciences Corporation on Use of its expresSF+® Cell Line for Gene Therapy - June 19th, 2012 [June 19th, 2012]
- Anti-cocaine vaccine described in Human Gene Therapy Journal - June 19th, 2012 [June 19th, 2012]
- bluebird bio Receives U.S. and European Orphan Drug Designation for Novel Gene Therapy to Treat Adrenoleukodystrophy - June 19th, 2012 [June 19th, 2012]
- Close to a cure: Greater Hartford takes on rare Jewish genetic disease - June 19th, 2012 [June 19th, 2012]
- Gene Therapy Helps Treat Children with Rare Brain Disorder - June 20th, 2012 [June 20th, 2012]
- Gold nanoparticles capable of 'unzipping' DNA - June 21st, 2012 [June 21st, 2012]
- ‘Gene-silencing’ drug can halt and reverse deadly brain disorder - June 21st, 2012 [June 21st, 2012]
- uniQure Collaborates with UCSF on GDNF Gene Therapy in Parkinson's Disease - June 22nd, 2012 [June 22nd, 2012]
- Gene-silencing method offers possible therapy for Huntington's disease - June 22nd, 2012 [June 22nd, 2012]
- Gene mutations cause massive brain asymmetry - June 24th, 2012 [June 24th, 2012]
- Research and Markets: Translational Regenerative Medicine - Oncology, CNS and Cardiovascular-Rich Pipeline Features ... - June 25th, 2012 [June 25th, 2012]
- Stress Blocks Gene That Guards Brain Against Depression - June 26th, 2012 [June 26th, 2012]
- Targeted gene therapy enhances treatment for Pompe disease - June 26th, 2012 [June 26th, 2012]